GH AXIS & LONGEVITY / COLOPHON
Contact the Editorial Desk
Correspondence on citations, corrections, and research-related inquiries about the GH-axis and longevity literature — the things a reference desk most needs to hear.
Editorial correspondence
pureformpeptide is glad to hear about the research record: a citation quoted inaccurately, a regulatory reference that has gone out of date, or a peer-reviewed study on NAD+, Ipamorelin, CJC-1295, or MOTS-c that should join the references page. The most useful notes point to a specific passage and include a DOI or PubMed ID for the proposed correction, and those get read carefully.
Editorial mailbox: editorial@pureformpeptide.com
Beyond the atlas's edge
pureformpeptide maps the literature; it is neither a clinical service nor a supplier, so several kinds of request fall past its edge:
- Advising on, recommending, or commenting on human use of any compound discussed here.
- Suggesting a dose, schedule, or route of administration for any individual — including questions about dosing protocols that circulate in online communities.
- Diagnosing a condition or judging whether a research finding applies to a particular person's situation.
- Selling, sourcing, identifying, recommending, or helping locate any compound from any supplier.
- Answering athlete anti-doping queries about Ipamorelin, CJC-1295, or MOTS-c, given that all three are prohibited substances in competitive sport.
Readers seeking guidance on any health matter should consult a licensed clinician in their own jurisdiction. Editorial correspondence is not guaranteed a reply and may be delayed; the mailbox is monitored intermittently.